Luis Borges Insider Profile

4 Followers
Luis Borges, SVP, Research at Five Prime Therapeutics, holds 69.32K shares in Metagenomi, Inc. (Ticker: MGX), holds 256.54K shares in Century Therapeutics (Ticker: IPSC), holds 71.62K shares in Five Prime Therapeutics (Ticker: FPRX).
tipranks
Luis Borges

Luis Borges
Five Prime Therapeutics (FPRX)
SVP, Research

Not Ranked
Luis Borges has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$522K
72.25%
27.75%
A breakdown of Luis Borges's holdings

Insider Roles

Century Therapeutics
(IPSC)
CSO
Metagenomi, Inc.
(MGX)
Chief Scientific Officer
Roles that Luis Borges holds in companies

Most Profitable Insider Trade

Stock:
Century Therapeutics
(IPSC)
Rating:Informative Sell
Date:Mar 23, 2023 - Mar 23, 2024
Return:-26.90%
The most profitable trade made by Luis Borges

Luis Borges's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
FPRX
Five Prime Therapeutics
Mar 03, 2017
Uninformative Sell
809.62K
$2.72M
Century Therapeutics
Apr 05, 2023
CSO
Uninformative Buy
7.68K
$377.11K
Metagenomi, Inc.
Apr 03, 2024
Chief Scientific Officer
Uninformative Buy
$144.87K
List of latest transactions for each holding click on a transaction to see Luis Borges's performance on stock

Luis Borges insider profile FAQ

What is the percentage of profitable transactions made by Luis Borges?
The percentage of profitable transactions made by Luis Borges is ―.
    What is the average return per transaction made by Luis Borges?
    The average return per transaction made by Luis Borges is ―.
      What stocks does Luis Borges hold?
      Luis Borges holds: FPRX, IPSC, MGX stocks.
        What was Luis Borges’s latest transaction?
        Luis Borges latest transaction was an Uninformative Buy of ―.
          What was Luis Borges's most profitable transaction?
          Luis Borges’s most profitable transaction was an Informative Sell of IPSC stock on March 23, 2023. The return on the trade was -26.90%.
            What is Luis Borges's role in Five Prime Therapeutics?
            Luis Borges's role in Five Prime Therapeutics is SVP, Research.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.